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ABSTRACT : 
Aromatase is the only enzyme responsible for the irreversible conversion of androgens into 
estrogens. Teleost fishes have two copies of the cyp19a1 gene that encode two isoforms of 
aromatase: cyp19a1a encodes ovarian aromatase, while the cyp19a1b gene encodes brain 
aromatase (aromatase B). We have shown that (i) aromatase B is strongly expressed in 
radial glial cells (RGC), that act as stem cells in mammals and fish and ii) the cyp19a1b gene 
is very sensitive to estrogens, through a mechanism that involves a well conserved ERE. 
This feature makes this gene an outstanding biomarker of xeno-estrogen exposures and we 
have developed and validated an in vivo assay allowing detection of estrogenic activity with a 
very high sensitivity. The in vivo assay is based on a transgenic zebrafish tg(cyp19a1b-GFP) 
line that expresses GFP in RGCs and we demonstrate the usefulness of the transgenic 
cyp19a1b-GFP as a reliable, sensitive and rapid in vivo estrogenic screening assay 
  
Introduction 
It is now well established that a number of natural and man-made compounds referred to as 
Endocrine Disrupting Chemicals (EDCs) interfere with the endocrine system of animals, 
including wildlife and humans. A growing number of environmental compounds have been 
proved or suspected to act as endocrine disruptors. EDCs belong to structurally and 
functionally diverse group of chemicals and include, among others, natural and synthetic 
steroids, phyto- and myco-estrogens, alkylphenols, phtalates, bisphenolA, 
polybrominateddiphenyl ethers (PBDE's), several pesticides, dioxins and polycyclic aromatic 
hydrocarbons (PAHs). In a regulatory perspective, these compounds have been defined as 
exogenous substances or mixture that alter function(s) of the endocrine system and 
consequently cause adverse health effects in an intact organism, or its progeny, or 
(sub)populations (WHO, 2002). They have been also defined according to their multiple 
modes of action on the endocrine system as exogenous agents that interfere with the 
production, release, transport, metabolism, binding, action, or elimination of natural 
hormones in the body responsible for the maintenance of homeostasis and the regulation of 
developmental processe (Kavlock et al., 1996). 
Because a large proportion of potential EDCs end up in surface waters, aquatic species are 
particularly vulnerable to their potential adverse effects. In fact, endocrine disruption has 
been demonstrated to occur in wildlife, particularly in aquatic species (Tyler et al., 1998) and 
there is strong evidence supporting a causal linkage between exposure and effect (Jobling et 
al., 1998; Sanchez et al., 2011). Until now, most of the EDCs effects reported on fish been 
concerned their peripheral actions such as gonadal development, oocyte development, egg 
production and fertilization, sperm count and liver vitellogenin synthesis, an estrogen-
dependent yolk precursor(for review see, e.g. (Hotchkiss et al., 2008). However, the 
reproductive axis also includes upper levels of regulation inthe central nervous system (CNS) 
that is likely to be targeted by a wide range of EDCs. For instance, we recently shown that 
the synthetic estrogen ethinylestradioland the alkyphenolic compound nonylphenol disrupt 
the ontogeny of GnRH system by inducing in a concentration-dependent manner the number 
of GnRH3 neurons in zebrafish embryos and larvae (Vosges et al., ; Vosges et al., 2010). 
These effects were observed as early as 5 days post-fertilisation and occurred at low and 
environmentally relevant concentrations. Furthermore, the effects ofnonylpenol and 
ethinylestradiol were shown to be blocked by the pure estrogen receptors (ERs) antagonist 
ICI 182-780, demonstrating the involvement of functional ERs in mediating their effects 
(Vosges et al.). The effects of EDCs upon neuroendocrine systems of fish are not limited to 
the GnRH neurons. For instance, other studies have shown the effects of several EDCs on 
the dopaminergic and serotoninergic circuits in fish (for a review see (Le Page et al., 2011)).  
Another target of the central nervous system of fish known to be affected by EDCs is 
brain aromatase B, encoded by the cyp19a1b gene. In all vertebrates, cytochrome P450 
aromatase (Cyp19a1) converts C19 androgens into C18 estrogens, important hormones 
involved in the control of many important physiological processes, notably reproduction. In 
vertebrates, with the notable exception of the pigs, aromatase is produced by a single 
Cyp19a1 gene, whose tissue specific expression is driven by alternative promoters (Simpson 
et al., 1994). Conversely, in many teleosts studied so far, including the model species 
zebrafish (Danio rerio), two structurally distinctcyp19a genes are found, cyp19a1a and 
cyp19a1b. These two genes generate two structurally and functionally different isoforms 
referred to as Aromatase A (AroA), predominantly expressed in gonads and Aromatase B 
(AroB), mainly found in neuronal tissues and responsible for the well-known exceptional 
aromatase activity of the brain of fish (Pasmanik and Callard, 1985; Gonzalez and Piferrer, 
2003). 
 
Expression of the cyp19a1b in the brain is regulated by estrogens (Menuet et al., 2005) and 
accumulating data acknowledge aromatase B as a highly and sensitive target of estrogens 
and an outstanding biomarker of xenoestrogens exposure. In the developing and adult brain, 
aromatase B expression is located exclusively in radial glial cells which are stem cells as 
they are capable of giving birth to newneurons. Given the key role of these cells in 
neurogenesis, modulation of brain aromatase expression due to EDCs raises the question of 
their potentialeffect on neurogenesis. 
Regulation of cyp19a1b expression in the brain of fish. 
The structure of the cyp19a1bgene pointed out the presence of a well-conserved estrogen–
response element (ERE) and a half ERE located within the 500bp of the cyp19a1b proximal 
promoter (Tchoudakova et al., 2001; Tong and Chung, 2003). Transactivation experiments 
using zebrafish cyp19a1b linked to luciferase revealed that, in the presence of estrogen 
receptors, 17β-estradiol(E2) up-regulates cyp19a1b. This up-regulation was however highly 
dependent on the cell context. Indeed, while no or weak activity of the promoter following E2 
treatment was observed in most cell lines studied (e.g., Hela, CHO), a dramatic luciferase 
activity was reported in cell line providing a glial or a neuro-glial cell context, i.e. U251-MG. 
Furthermore, deletions or mutations studies indicated that integrity of the ERE is absolutely 
required for the estrogenic regulation (Menuet et al., 2005). But ERs are not sufficient to 
drive cyp19a1b expression in the brain of fish in the presence of estrogens. In fact, it was 
shown that a sequence, referred to as GxRE located between -277 and -257 bp from the 
initiation start site, plays an important role in the cell specific regulation of the cyp19a1b gene 
and its E2-regulation (Le Page et al., 2008). The cyp19a1b regulation requires glial specific 
factor(s) that bind to a glial x responsive element (GxRE)acting synergistically with the ERE 
sequences (Le Page et al., 2008).This mechanism confers to the cyp19a1b gene a high 
sensitivity to estrogens and a cell-specific expression in radial glial cells (figure 1). In 
agreement with in vitro studies, it isnow well-established that short-term exposure of 
zebrafish embryos 17beta-estradiol (E2) for two days causes a strong increase in cyp19a1b 
mRNAs, Cyp19a1b protein expression in radial glial cells, and aromatase activity in the head. 
All these effects can be blocked by an excess of ICI 182 780, indicating the requirement of 
functional estrogen receptors (ERs) in mediating the effect of E2 on cyp19a1b expression 
(Menuet et al., 2005). In contrast, the cyp19a1a gene that encodes gonadal aromatase is 
poorly sensitive to estrogens at this stage of development (Hinfray et al., 2006; Cheshenko et 
al., 2007). 
Effect of endocrine disruptors on cyp19a1b expression.  
The studies mentioned above clearly demonstrate the estrogenic regulation of the brain 
aromatase cyp19a1b gene in radial glial cell context both in vitro and in vivo and revealed 
that aromatase B is very sensitive to estrogens through ER-dependent mechanisms. Many 
environmental compounds belonging to various chemical families have been shown to bind 
and activate ERs. Among EDCs, synthetic steroidal estrogens (including the pharmaceutical 
17α-ethinylestradiol) are some of the major and most potent estrogenic contaminants in the 
aquatic environment. Recently, we precisely documented the spatio-temporal expression of 
AroB within the central nervous system during the early development of control and EE2-
exposed zebrafish. The strong and precocious up-regulation of AroB expression was 
observed in the brain of EE2-treated larvae as early as 5 dpf for EE2 concentration as low as 
0.02 nM (figure 2). At 5 dpf, AroB-immunoreactive cells were located in the caudal olfactory 
bulbs, the telencephalon, the preoptic region, the optic tecta, the rostral hypothalamus  and 
caudal hypothalamus and bordering the fourth ventricle up to the spinal cord. This 
expression pattern of AroB immunoreactivity in the brain remained unchanged but the 
intensity of AroB immunoreactivity increased during development demonstrating that up-
regulation of AroB was time-dependent and EE2 concentration-dependent. This study 
confirms and further illustrates the extreme sensitivity of the zebrafish brain aromatase to 
(xeno)-estrogens by demonstrating that short exposures to low and environmentally relevant 
concentrations of EE2 are able to strongly induce the expression of AroB in radial glial cells 
in early life stages. 
In addition to potent agonist ligands of the estrogen receptors, studies in zebrafish have 
demonstrated that weak estrogenic compounds such as genistein and zearalenone, 
individually or in combination are able to modulate cyp19a1b gene transcription at its 
promoter level. (Le Page et al., 2006). In vivo,, the alkylphenolic compound NP is able to 
induce cyp19a1b mRNA levels (Kazeto et al., 2004) and aromatase B protein expression in a 
concentration-dependent manner in radial glial cells of developing embryos, this effect being 
blocked by ICI 182-780 (Vosges et al.). 
 
These data provide the rationale for using the cyp19a1b gene as an outstanding biomarker 
for xeno-estrogens. Recently, a transgenic zebrafish that expresses green fluorescent 
protein (GFP) driven by the zebrafish brain aromatase cyp19a1b promoter was generated 
(Tong et al., 2009). This cyp19a1b-GFP transgenic line faithfully mimics the expression and 
the regulation of endogenous AroB expression in radial glial cells. Based on the use of the 
cyp19a1b-GFP transgenic, we developed and validated a novel in vivo assay to detect and 
to quantify the estrogenic potencies of chemicals. In our assay, zebrafish embryos are 
exposed from 0 to 5 days post-fertilization to chemical substances and GFP expression is 
quantified in vivo using fluorescence microscopy and image analysis (figure 3). Several 
estrogenic compounds belonging to various chemical families have been tested and includes 
natural and synthetic estrogens, phyto and myco-estrogens, alkylphenolic compounds 
several pesticides, etc. We showed that exposure of tg(cyp19a1b-GFP) embryos to various 
xeno-estrogens induces GFP expression in a concentration-dependent manner and 
demonstrated the sensitivity of the assay as evidence by the extremely low concentration of 
EE2 required to induce GFP expression. For instance, concentrations of EE2 as low as 5 pM 
are sufficient to up-regulate GFP expression in zebrafish embryos. In addition to xeno-
estrogens, we have evaluated the effects of several Aryl hydrocarbon Receptor (AhR) 
ligands. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), or Benzo[a]Pyrene (B[a]P) did not affect 
GFP expression in vivo. However, when tg(cyp19a1b-GFP) embryo were co-exposed TCDD 
and E2, we have shown the attenuation of estrogen-induced up-regulation of GFP 
expression, showing that TCDD has anti-estrogenic effect which is in agreement with 
previously reported data on the expression of zebrafish aromatase cyp19a1b gene in 
response to TCDD (Cheshenko et al., 2007).  
Our data demonstrate the usefulness of the transgenic cyp19a1b-GFP as a reliable, 
sensitive and rapid in vivo estrogenic screening assay that could, together with fish-specific 
estrogenic in vitro assays (Le Page et al., 2006; Cosnefroy et al., In press), enhance the 
efficiency and accuracy of EDCs testing strategies for environmental hazard and risk 
assessment of chemical substances.  
Conclusion  
Recent studies have now identified a number of brain targets for xeno-estrogen commonly 
present in environmentally relevant concentrations in surface waters. The most prominent 
effect of EDCs, in zebrafish is their impact on the cyp19a1b gene that encodes aromatase B 
in the brain. Detailed molecular and whole animal studies in wild-type and transgenic 
cyp19a1b-GFP zebrafish demonstrated the extreme sensitivity of the cyp19a1b gene to 
xeno-estrogens. A striking feature of fishes is that aromatase expression is restricted to 
radial glial cells that behave as progenitors in developing and adult zebrafish. The 
consequences of disruption of cyp19a1b gene in radial glial cells are still unknown but may 
have important functional implications. Given that our recent studies demonstrated that 
estrogens modulate proliferative activity of radial glia progenitors, it is likely that (xeno)-
estrogen have similar activity and thus the potential outcome requires thorough 
investigations. In any case, those studies have led to the development of a very sensitive in 
vivo assay that makes use of cyp19a1b-GFP transgenic embryos.  
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Figure 1. Schematic representation of regulation of the cyp19a1b gene by estradiol in radial 
glial cells. AhR: binding site for the aryl hydrocarbon receptor; CRE: item responses to the 
cyclic AMP ERE: estrogen response element; GxRE: response element factor glial-specific 
(Gx) TATA: TATA box; E2: estradiol, T: testosterone; X: xenoestrogens. Adapted from 
Mouriec et al. (2008). 
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Figure 2. Photomicrographs of expression of AroB-ir cells (red) on transversal sections of 5-
dpf old zebrafish larvae control and exposed to  nM and 0.5nM of EE2 at the level of the 
preoptic area (200× magnification).  Blue: Hoechst staining. Scale bars = 20µm. 
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Figure 3. In vivo imaging of live transgenic cyp19a1b-GFP zebrafish embryos A/ In control 
fish, GFP expression is weakly detectable in the preoptic area. B/ In EE2-exposed embryos a 
stronger fluorescence signal with a much wider distribution was observed and quantified by 
image analysis C/ Quantification of GFP induction using image analysis in transgenic 
cyp19a1b-GFP zebrafish embryos exposed to increasing concentrations of EE2. The 
effective concentration EC50 is 0.013nM and the lowest observed effect concentration is 
equal to 5pM. Each point is a mean of n=10 individus, N=4 independent experiments  
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